US Patent Issued to ELI LILLY and Co. on Dec. 9 for "Formulations of a farnesoid X receptor agonist" (California Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,160, issued on Dec. 9, was assigned to ELI LILLY AND COMPANY (Indianapolis).

"Formulations of a farnesoid X receptor agonist" was invented by Nicholas D. Smith (San Diego) and Robert Mansfield (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are pharmaceutical formulations of a farnesoid X receptor agonist, 4-((4-(1-(tert-butyl)-1H-pyrazol-4-yl)pyridin-2-yl)((4-(4-methoxy-3-methylphenyl)bicyclo[2.2.2]octan-1-yl)methyl)carbamoyl)cyclohexyl 3-hydroxyazetidine-trans-1-carboxylate, and methods of using such pharmaceutical formulations in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor act...